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1. Main Messages
•	 The	Indigenous	Health	Service	Delivery	(IHSD)	Template	has	been	developed	to	overcome	lack	of	Indigenous	
specific	evidence	for	use	in	economic	evaluations
•	 The	IHSD	Template	allows	evidence	of	intervention	costs	and	effectiveness	collected	from	mainstream	services	
to	be	adapted	so	that	interventions	can	be	evaluated	as	if	delivered	from	an	Aboriginal	Community	Controlled	
Health	Service	(ACCHS)
•	 The	IHSD	Template	identifies	and	values	the	additional	components	involved	in	the	delivery	of	health	
interventions	via	ACCHS	compared	to	mainstream	GP	practice
•	 IHSD	Template	values	reveal	greater	costs	associated	with	providing	interventions	via	ACCHS	due	to	the	
comprehensive	nature	of	these	services.	This	is	accompanied	by	improved	Indigenous	access	to	health	services,	
illustrated	by	higher	rates	of	Indigenous	utilisation	of	ACCHS	and	adherence	to	treatments	prescribed	compared	
to	mainstream	GP	practice
•	 As	a	result,	the	ACE-Prevention	economic	evaluations	are	made	more	relevant	to	the	Indigenous	population	for	
use	in	priority	setting	within	the	Indigenous	context
2. Background
In	ACE-Prevention,	separate	economic	evaluations	have	been	performed	for	the	Indigenous	and	general	Australian	
populations	to	account	for	differences	in	the	target	disease	burden,	the	prevalence	and	distribution	of	harmful	
exposures,	the	way	in	which	health	interventions	are	delivered	and	their	effectiveness.	These	differences	need	to	be	
taken	into	account	in	the	conduct	of	economic	analyses;	in	particular	in	the	identification,	measurement	and	valuation	
of	intervention	costs	and	benefits.
Qualitative	evidence	suggests	a	‘best	practice’	model	of	primary	healthcare	delivery	for	Indigenous	populations	is	
based	on	self-determination	and	community	control,	epitomised	by	the	ACCHS	model	of	comprehensive	primary	
health	care.	For	this	reason,	the	ACE-Prevention	project	set	out	to	evaluate	the	impact	of	delivering	interventions	to	the	
Indigenous	population	via	this	health	service	type.	However,	there	was	a	lack	of	quantitative	evidence	of	effectiveness	
for	interventions	delivered	from	ACCHS	on	which	to	base	economic	evaluations.	To	overcome	this,	the	IHSD	Template	
has	been	developed.
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“The Aboriginal and Torres Strait Islander component of ACE-Prevention was 
supported by the Cooperative Research Centre for Aboriginal Health (CRCAH). 
In January 2010, the CRCAH was refunded by the CRC Program and renamed 
the Cooperative Research Centre for Aboriginal and Torres Strait Islander Health 
(CRCATSIH), and incorporated into The Lowitja Institute – Australia’s National 
Institute for Aboriginal and Torres Strait Islander Health Research.
3. tHe indigenous HealtH serVice deliVery (iHsd) teMplate
The	IHSD	Template	is	comprised	of	components	which	describe	the	additional	activities	provided	by	ACCHS	compared	to	mainstream	GP	
practice,	and	their	impacts	on	the	cost	of	delivering	interventions	and	their	benefits	on	health	for	the	Indigenous	population.	These	can	be	
described	in	terms	of	the	differences	between	the	two	service	types	and	are	detailed	in	Box	1.	The	Template	transforms	mainstream	effectiveness	
data	so	that	economic	evaluations	can	be	performed	on	interventions	as if	they	were	delivered	from	an	ACCHS.	Information	used	to	construct	
the	IHSD	Template	has	been	obtained	from	the	pubic	literature,	along	with	interviews	with	people	working	within	the	ACCHS	sector.
Box 1. The Indigenous Health Service Delivery (IHSD) Template components
Differences in how health interventions are delivered between ACCHS compared to mainstream GP practice
•	 Basic health intervention delivery characteristics:
- Role substitution – a patient may be seen by an Aboriginal Health Worker or a nurse in addition to, or 
instead of, a doctor
- Compliance management – e.g. medication dosing and appointment recalls
- Staff training activities – e.g. cultural in addition to professional training for non-Aboriginal staff
- Emphasis on home visits
- Time spent on paperwork, case conferencing and the management of complex medical conditions
- Seeing of other family members as part of routine consultations
•	 Population health, social and community activities:
- Provision of other services – e.g. social work and counselling
- Provision of services usually provided by outside agencies – e.g. financial and housing assistance
- Health promotion and community development activities
- Provision of a community space
•	 Management and governance structures:
- Presence of a community management board and the associated need for community capacity building 
in management
- Additional management resources required for overseeing larger staff numbers and multiple projects
•	 Patient transport services
- Provision of transport for patients to and from appointments
•	 Provision of services to a large remote population
- Out of hours emergency care
- Outreach services
- Housing and relocation costs for staff
- Additional costs associated with pharmaceutical and pathology services
•	 Differences in rates of Indigenous utilisation of services and adherence to treatments when 
interventions are delivered from ACCHS compared to mainstream GP clinics
•	 Differences in future cost offsets (cost savings) for future treatment of Indigenous compared to 
non-Indigenous patients
For	the	relevant	IHSD	Template	components	listed	in	Box	1,	values	have	been	determined	for	both	the	additional	costs	involved	each	time	a	
patient	visits	an	ACCHS	compared	to	a	mainstream	GP	practice,	and	also	for	the	differences	in	rates	of	Indigenous	utilisation	and	adherence	for	
the	health	service	types.	A	ratio	of	the	differences	in	future	cost	offsets	for	the	Indigenous	compared	to	the	non-Indigenous	population	has	also	
been	established,	and	these	are	all	shown	in	Tables	1	and	2.	Additional	costs	have	been	attributed	to	a	single	‘encounter’	with	a	health	service	
practitioner,	as	this	then	allows	the	intervention	costs	to	be	adjusted	according	to	the	number	of	health	practitioner	visits	that	are	involved	in	the	
‘event	pathway’	for	an	intervention.	Calculated	costs	exclude	services	not	directly	related	to	health	care	delivery	that	may	be	provided	by	ACCHS	
such	as	legal	services.
Table	1.	The	additional	costs	of	IHSD	Template	components
IHSD Template component category Additional cost per ACCHS patient 
encounter
Basic health intervention delivery components $16.67-$31.57 
(depending on consultation length)
Population health, social and community activities $9.28
Management and governance $3.87
Patient transport services $47.01
Services to remote regions $5.50
Table	2.	IHSD	Template	values	(average	across	all	services)
Mainstream GP 
services
ACCHS
Short consultation cost $ 30.85 $ 113.18
Indigenous utilisation rate (cf. non-Indigenous) 60.0 % 73.2 %
Indigenous adherence rate (cf. non-Indigenous) 77.8 % 95.7 %
Cost-offsets ratio (Indigenous : non-Indigenous) 1.19 1.19
The	IHSD	Template	values	shown	in	Table	2	reveal	that	the	costs	of	providing	consultations	via	ACCHS	are	higher	than	in	mainstream	GP	
practices,	primarily	due	to	the	comprehensive	nature	of	these	services.	In	particular,	the	provision	of	patient	transport	contributes	approximately	
50%	of	the	additional	cost	(see	Table	1).	In	addition,	improved	access	to	health	services	for	the	Indigenous	population	is	illustrated	by	higher	
rates	of	Indigenous	utilisation	of	ACCHS	and	adherence	to	treatments	compared	to	mainstream	GP	services,	thereby	increasing	intervention	
effectiveness	when	delivered	from	ACCHS.	Cost-offsets	are	greater	for	the	Indigenous	population	irrespective	of	which	health	service	type	is	
used,	indicating	increased	disease	treatment	costs	for	Indigenous	patients	due	to	greater	co-morbidities	and	severity	of	disease,	and	therefore	
greater	potential	cost-savings	as	a	result	of	interventions.
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4. using tHe iHsd teMplate
The	IHSD	Template	has	been	trialled	in	a	few	economic	evaluations	in	the	prevention	of	diabetes,	cardiovascular	and	renal	
disease,	and	these	results	are	detailed	in	the	Indigenous	population	results	pamphlets	as	part	of	this	series.	The	data	for	these	
interventions	taken	from	mainstream	GP	services	are	adapted	to	the	ACCHS	setting	using	the	IHSD	Template	values	from	
Table	2	prior	to	economic	evaluation.	For	example,	if	an	intervention	entails	one	short	GP	consultation,	the	cost	of	$30.85	for	
mainstream	GP	services	is	substituted	to	$113.18	in	the	event	pathway	when	delivered	from	an	ACCHS.	Similarly,	the	utilisation	
of	health	services	by	the	Indigenous	population	is	taken	to	be	60.0%	for	mainstream	GP	services,	increasing	to	73.2%	for	
ACCHS.	Therefore,	the	IHSD	Template	allows	the	resulting	cost-effectiveness	ratios	to	take	these	differences	in	treatment	costs,	
utilisation	and	adherence	rates	into	account	when	economic	evaluations	are	performed.	This	is	in	addition	to	differences	in	
Indigenous	population	demographics	and	disease	risk	which	are	adjusted	for	separately	in	the	modelling	of	health	outcomes.	
As	a	result,	the	ACE-Prevention	economic	evaluations	are	made	more	relevant	to	the	Indigenous	population	for	use	in	priority	
setting	within	the	Indigenous	context.
For	more	information	on	this	topic	area,	please	visit	website	www.sph.uq.edu.au/bodce-ace-prevention
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